FDA cleared platform CyMedica Orthopedics offers e-vive, an FDA-cleared, app-based muscle stimulation and patient engagement system, presenting a ready-to-market digital therapeutic solution for knee osteoarthritis and post-surgical rehab, which can be positioned to clinics and rehab centers seeking compliant, tech-enabled rehabilitation tools.

Expansion opportunity Recent launch of Motive Knee as an FDA-cleared device expands product line and barefoot prescription requirements, enabling sales conversations with orthopedic practices, physical therapy groups, and durable medical equipment distributors seeking diverse knee rehabilitation solutions.

Clinical data value The platform collects rehabilitation data to measure patient progress, offering a data asset for outcomes tracking and value-based care discussions with hospitals and clinics looking to demonstrate improved recovery metrics and patient engagement.

Strategic partnerships With a lean team and focus on surgical rehabilitation, CyMedica can leverage relationships with OEMs, distributors, and integrated care systems in orthopedics to expand reach, especially against larger players by highlighting ease of adoption and FDA clearance.

Growth signals Funding activity in the past and the recent product launch indicate momentum in a niche market for knee rehab tech; sales should target mid to large orthopedic groups, sports medicine clinics, and post-surgical rehab programs that require scalable, wearable-based therapy solutions.